We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 647 results
  1. Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?

    Dyslipidaemias are major cardiovascular risk factors, especially in people with diabetes. In this area, next-generation therapies targeting...

    Sophie Béliard, Florian Mourre, René Valéro in Diabetologia
    Article Open access 20 February 2024
  2. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets

    Lipid droplet formation is a defining histological feature in clear-cell renal cell carcinoma (ccRCC) but the underlying mechanisms and importance of...

    Sze Kiat Tan, Helen Y. Hougen, ... Scott M. Welford in Nature Reviews Urology
    Article 03 October 2022
  3. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells

    Purpose

    ATP-citrate lyase (ACLY) is a critical enzyme at the intersection of glucose and lipid metabolism. ACLY is often upregulated or activated in...

    Shou-Sen Huang, Chung-Hsin Tsai, ... Shih-** Cheng in Endocrine
    Article 27 June 2022
  4. How Will Our Practice Change After the CLEAR Outcomes Trial?

    Purpose of Review

    Bempedoic acid is a novel therapeutic agent that is designed to reduce levels of low-density lipoprotein cholesterol (LDL-C). The...

    Timothy Abrahams, Adam J. Nelson, Stephen J. Nicholls in Current Atherosclerosis Reports
    Article Open access 31 January 2024
  5. Bempedoic Acid: for Whom and When

    Purpose of Review

    The aim of creating an orally active non-statin cholesterol-lowering drug was achieved with bempedoic acid, a small linear molecule...

    Massimiliano Ruscica, Cesare R. Sirtori, ... Alberto Corsini in Current Atherosclerosis Reports
    Article Open access 28 July 2022
  6. Primäre Fettstoffwechselstörungen – Stellenwert in aktuellen Dyslipidämieleitlinien und therapeutische Innovationen

    According to current guidelines, the selection and intensity of lipid-effective therapies are based on the risk to be treated. The sole clinical...

    G. Klose, I. Gouni-Berthold, W. März in Die Innere Medizin
    Article 06 June 2023
  7. Bempedoic Acid: A New Non-statin Drug for the Treatment of Dyslipidemia

    Statins are currently the first-line drugs for managing dyslipidemia due to their substantial clinical efficacy in reducing low-density lipoprotein...

    Surasak Wichaiyo, Wasu Supharattanasitthi in Clinical Drug Investigation
    Article 25 August 2021
  8. Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention

    Despite treatment with statins, patients with elevated low-density lipoprotein cholesterol (LDL-C) and triglycerides remain at increased risk for...

    Daniel Tobias Michaeli, Julia Caroline Michaeli, ... Thomas Michaeli in American Journal of Cardiovascular Drugs
    Article Open access 24 July 2023
  9. The impact of ATP-binding cassette transporters on metabolic diseases

    Currently, many people worldwide suffer from metabolic diseases caused by heredity and external factors, such as diet. One of the symptoms of...

    Zixiang Ye, Yifei Lu, Tao Wu in Nutrition & Metabolism
    Article Open access 03 August 2020
  10. Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension

    The primary and secondary prevention strategies of atherosclerotic cardiovascular disease (ASCVD) largely rely on the management of arterial...

    Guido Grassi, Rita Del Pinto, ... Claudio Ferri in High Blood Pressure & Cardiovascular Prevention
    Article Open access 03 January 2022
  11. New Strategies for Lowering Low-Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention

    Purpose of Review

    The primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on optimizing cardiovascular health...

    Sean Paul Gaine, Renato Quispe, ... Erin D. Michos in Current Cardiovascular Risk Reports
    Article 25 June 2022
  12. PRSS37 deficiency leads to impaired energy metabolism in testis and sperm revealed by DIA-based quantitative proteomic analysis

    Our previous studies have reported that a putative trypsin-like serine protease, PRSS37, is exclusively expressed in testicular germ cells during...

    Wenfeng **ong, Haoyang Ge, ... Zhugang Wang in Reproductive Sciences
    Article 26 April 2022
  13. The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry

    The scope and variety of the metabolic intermediates from the mitochondrial tricarboxylic acid (TCA) cycle that are engaged in epigenetic regulation...

    Xujun Liu, Wenzhe Si, ... Yongfeng Shang in Signal Transduction and Targeted Therapy
    Article Open access 03 November 2021
  14. Metabolism-secretion coupling in glucose-stimulated insulin secretion

    Pancreatic β-cells in the islets of Langerhans secrete insulin in response to blood glucose levels. Precise control of the amount of insulin secreted...

    Hisamitsu Ishihara in Diabetology International
    Article 19 March 2022
  15. Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases

    Metabolic disorders of cardiomyocytes play an important role in the progression of various cardiovascular diseases. Metabolic reprogramming can...

    Lixiao Hang, Ying Zhang, ... Lin **a in Cardiovascular Drugs and Therapy
    Article 18 January 2024
  16. Calcium citrate: from biochemistry and physiology to clinical applications

    Adequate daily calcium intake should normally be achieved by dietary sources. Since low calcium diets are quite common in subjects that do not reach...

    Andrea Palermo, Anda Mihaela Naciu, ... Alberto Falchetti in Reviews in Endocrine and Metabolic Disorders
    Article 01 September 2019
  17. Role of Bempedoic Acid in Clinical Practice

    Many patients do not achieve optimal low-density lipoprotein cholesterol (LDL-C) levels with statins alone; others are unable to tolerate statin...

    Christie M. Ballantyne, Harold Bays, ... Joseph J. Saseen in Cardiovascular Drugs and Therapy
    Article Open access 05 April 2021
  18. Metabolic adaptations in pressure overload hypertrophic heart

    This review article offers a detailed examination of metabolic adaptations in pressure overload hypertrophic hearts, a condition that plays a pivotal...

    **feng Wei, Xuefei Duan, ... Sheng Wang in Heart Failure Reviews
    Article 28 September 2023
  19. HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity

    Purpose

    HER2-positive breast cancer has a high chance of achieving pathological complete response when HSD17B4 , responsible for peroxisomal...

    Nobuaki Arai, Naoko Hattori, ... Toshikazu Ushijima in Breast Cancer Research and Treatment
    Article 28 June 2023
Did you find what you were looking for? Share feedback.